tiprankstipranks
Trending News
More News >
Telix Pharmaceuticals Ltd. (AU:TLX)
ASX:TLX
Australian Market

Telix Pharmaceuticals (TLX) Financial Statements

Compare
328 Followers

Telix Pharmaceuticals Financial Overview

Telix Pharmaceuticals's market cap is currently $8.23B. The company's EPS TTM is AU$0.06; its P/E ratio is 160.99; Telix Pharmaceuticals is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is AU$0.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueAU$ 783.21MAU$ 502.55MAU$ 160.10MAU$ 7.60MAU$ 5.21M
Gross ProfitAU$ 509.68MAU$ 314.39MAU$ 29.34MAU$ -29.77MAU$ -16.88M
Operating IncomeAU$ 82.13MAU$ 51.89MAU$ -73.18MAU$ -81.25MAU$ -49.25M
EBITDAAU$ 92.55MAU$ 22.97MAU$ -92.84MAU$ -70.07MAU$ -44.94M
Net IncomeAU$ 49.92MAU$ 5.21MAU$ -104.08MAU$ -80.51MAU$ -44.89M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 710.35MAU$ 123.24MAU$ 116.33MAU$ 22.04MAU$ 77.94M
Total AssetsAU$ 1.52BAU$ 398.30MAU$ 260.59MAU$ 109.81MAU$ 164.44M
Total DebtAU$ 581.45MAU$ 17.45MAU$ 10.45MAU$ 2.54MAU$ 2.21M
Net DebtAU$ -128.90MAU$ -105.79MAU$ -105.88MAU$ -19.50MAU$ -75.74M
Total LiabilitiesAU$ 948.22MAU$ 249.39MAU$ 178.44MAU$ 106.17MAU$ 84.44M
Stockholders' EquityAU$ 568.21MAU$ 148.91MAU$ 80.01MAU$ 2.16MAU$ 79.02M
Cash Flow
Free Cash FlowAU$ 9.00MAU$ 13.09MAU$ -77.83MAU$ -60.67MAU$ 1.64M
Operating Cash FlowAU$ 43.03MAU$ 23.88MAU$ -63.97MAU$ -59.33MAU$ 1.96M
Investing Cash FlowAU$ -135.17MAU$ -25.49MAU$ -17.00MAU$ -2.73MAU$ -1.09M
Financing Cash FlowAU$ 638.92MAU$ 10.19MAU$ 174.96MAU$ 2.85MAU$ 34.12M
Currency in AUD

Telix Pharmaceuticals Earnings and Revenue History

Telix Pharmaceuticals Debt to Assets

Telix Pharmaceuticals Cash Flow

Telix Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis